Raymond James Financial Reaffirms Underperform Rating for Sabra Healthcare REIT (NASDAQ:SBRA)

Sabra Healthcare REIT (NASDAQ:SBRA)‘s stock had its “underperform” rating reissued by stock analysts at Raymond James Financial in a report issued on Wednesday, MarketBeat.com reports.

SBRA has been the topic of several other research reports. Truist Financial upped their target price on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “hold” rating in a report on Friday, March 13th. Cantor Fitzgerald boosted their price target on Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “neutral” rating in a report on Monday, May 11th. Citigroup lifted their price target on Sabra Healthcare REIT from $21.00 to $24.00 and gave the company a “buy” rating in a report on Wednesday, February 18th. UBS Group increased their price objective on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the stock a “neutral” rating in a report on Wednesday, May 13th. Finally, Scotiabank boosted their target price on shares of Sabra Healthcare REIT from $21.00 to $22.00 and gave the company a “sector perform” rating in a report on Thursday, May 21st. Five research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $22.40.

Sabra Healthcare REIT Price Performance

Shares of SBRA traded down $0.09 during mid-day trading on Wednesday, hitting $18.47. The company’s stock had a trading volume of 79,492 shares, compared to its average volume of 2,587,025. The company has a current ratio of 4.72, a quick ratio of 4.72 and a debt-to-equity ratio of 0.96. Sabra Healthcare REIT has a 1-year low of $17.17 and a 1-year high of $21.28. The firm has a market capitalization of $4.66 billion, a P/E ratio of 29.32, a P/E/G ratio of 1.38 and a beta of 0.65. The firm has a 50-day simple moving average of $20.01 and a 200 day simple moving average of $19.68.

Sabra Healthcare REIT (NASDAQ:SBRA) last released its quarterly earnings data on Wednesday, April 29th. The real estate investment trust reported $0.16 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.16. The firm had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. Sabra Healthcare REIT had a return on equity of 5.60% and a net margin of 19.22%.Sabra Healthcare REIT’s revenue was up 20.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.37 earnings per share. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. Analysts predict that Sabra Healthcare REIT will post 1.51 EPS for the current fiscal year.

Institutional Trading of Sabra Healthcare REIT

Several institutional investors and hedge funds have recently bought and sold shares of the company. PNC Financial Services Group Inc. increased its holdings in shares of Sabra Healthcare REIT by 2.3% in the 4th quarter. PNC Financial Services Group Inc. now owns 23,807 shares of the real estate investment trust’s stock valued at $451,000 after acquiring an additional 528 shares during the last quarter. Larson Financial Group LLC boosted its stake in Sabra Healthcare REIT by 42.3% in the third quarter. Larson Financial Group LLC now owns 1,860 shares of the real estate investment trust’s stock valued at $35,000 after acquiring an additional 553 shares during the period. Anchor Investment Management LLC grew its holdings in shares of Sabra Healthcare REIT by 15.5% during the third quarter. Anchor Investment Management LLC now owns 4,150 shares of the real estate investment trust’s stock valued at $77,000 after purchasing an additional 556 shares during the last quarter. Inspire Investing LLC raised its position in shares of Sabra Healthcare REIT by 2.3% during the 4th quarter. Inspire Investing LLC now owns 24,747 shares of the real estate investment trust’s stock worth $469,000 after purchasing an additional 565 shares during the period. Finally, Oppenheimer & Co. Inc. raised its position in shares of Sabra Healthcare REIT by 1.7% during the 3rd quarter. Oppenheimer & Co. Inc. now owns 33,984 shares of the real estate investment trust’s stock worth $633,000 after purchasing an additional 581 shares during the period. Institutional investors and hedge funds own 99.40% of the company’s stock.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net‐lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long‐term, triple‐net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post‐acute rehabilitation and research and development laboratories.